(Q79888575)

English

High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation

scientific article published on 01 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

stem cell transplantation

1 reference

based on heuristic

inferred from title

Jakob R. Passweg

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

13

object named as

Gratwohl A

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Matthew B. Stern

2

object named as

Stern M

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Buser AS

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bucher C

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Arber C

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Heim D

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Halter J

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Meyer-Monard S

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Stussi G

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Lohri A

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ghielmini M

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Tichelli A

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

39

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

335-340

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17342158%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705597

0 references

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

The graft-versus-lymphoma effect: clinical review and future opportunities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative Malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic cell transplantation as consolidation immunotherapy of cancer after autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Tandem transplantation in lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem cell transplantation for the non-Hodgkin's lymphomas and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

The fate of human Langerhans cells in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cell recovery after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705597

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79888575&oldid=1758779811"